C109-0616 Screening compound: 6-bromo-N-[2-(4-chlorophenyl)ethyl]-3-(2,6-difluorophenyl)-4-hydroxy-2-oxo-1,2,3,4-tetrahydroquinazoline-4-carboxamide

C109-0616 Screening compound: 6-bromo-N-[2-(4-chlorophenyl)ethyl]-3-(2,6-difluorophenyl)-4-hydroxy-2-oxo-1,2,3,4-tetrahydroquinazoline-4-carboxamide
C109-0616 Screening compound: 6-bromo-N-[2-(4-chlorophenyl)ethyl]-3-(2,6-difluorophenyl)-4-hydroxy-2-oxo-1,2,3,4-tetrahydroquinazoline-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C109-0616
6-bromo-N-[2-(4-chlorophenyl)ethyl]-3-(2,6-difluorophenyl)-4-hydroxy-2-oxo-1,2,3,4-tetrahydroquinazoline-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C109-0616

Molecular Formula

C23H17BrClF2N3O3 (C23 H17 BrClF2 N3 O3)

Compound Name

6-bromo-N-[2-(4-chlorophenyl)ethyl]-3-(2,6-difluorophenyl)-4-hydroxy-2-oxo-1,2,3,4-tetrahydroquinazoline-4-carboxamide

IUPAC name

6-bromo-N-[2-(4-chlorophenyl)ethyl]-3-(26-difluorophenyl)-4-hydroxy-2-oxo-1234-tetrahydroquinazoline-4-carboxamide

SMILES

OC(C(NCCc(cc1)ccc1Cl)=O)(c(cc(cc1)Br)c1N1)N(c(c(F)ccc2)c2F)C1=O

InChI

InChI=1S/C23H17BrClF2N3O3/c24-14-6-9-19-16(12-14)23(33,21(31)28-11-10-13-4-7-15(25)8-5-13)30(22(32)29-19)20-17(26)2-1-3-18(20)27/h1-9,12,33H,10-11H2,(H,28,31)(H,29,32)/t23-/m1/s1

InChI Key

QEWYAEJBIBDXIN-HSZRJFAPSA-N

MDL Number (MFCD)

MFCD14720197

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

536.76

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.103

Distribution Coefficient, logD

5.103

Water Solubility, LogSw

-5.14

Polar Surface Area

66.345

Acid Dissociation Constant (pKa)

10.47

Base Dissociation Constant (pKb)

-0.27

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

13.00

C109-0616 in Drug Discovery

Included in Screening Libraries

KRAS-Targeted Library (16000 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with C109-0616 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C109-0616?
Check Price and Availability of C109-0616, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C109-0616 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C109-0616
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C109-0616
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C109-0616 available by request